covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

pharmafile | July 22, 2020 | News story | Research and Development COVID-19, coronavirus 

The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies, while the first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing.

In other news, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it, while the Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention (CDC) and instead to a central database in Washington, DC.

1. Trump administration orders hospitals to stop sending COVID-19 data to the CDCPublished on 16/07/20

The Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention (CDC) and instead to a central database in Washington, DC.

2. Moderna’s COVID-19 vaccine candidate set for final testing in the USPublished on 15/07/20

The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing.

3. Israeli doctor tests positive for coronavirus 3 months after recoveringPublished on 20/07/20

An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it.

4. UK secures early access to 90 million doses of coronavirus vaccinesPublished on 20/07/20

The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.

5. Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data showPublished on 20/07/20

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company has just revealed promising data on the interferon beta-based therapy, known as SNG001, in the treatment of patients hospitalised with the disease.

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …

moderna_norwood_plant

Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content